Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K130474
    Date Cleared
    2013-05-31

    (95 days)

    Product Code
    Regulation Number
    878.4010
    Reference & Predicate Devices
    Predicate For
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    SURGISEAL Topical Skin Adhesive is intended for topical applications only to hold closed easily approximated skin edges of wounds from surgical incisions, including punctures from minimally invasive surgery, simple, thoroughly cleansed, trauma induced lacerations.

    SURGISEAL may be used in conjunction with, but not in place of, deep dermal sutures.

    Device Description

    SURGISEAL Stylus and Stylus Twist Topical Skin Adhesive are sterile, professional liquid topical skin adhesives containing a monomeric (2-octyl cyanoacrylate) formulation and the colorant D & C Violet #2. Each applicator is comprised of a plastic ampoule container contained within an applicator sleeve with the applicator tip.

    This Stylus applicator tray is contained in an outer Tyvek pouch. When SURGISEAL is applied to the skin, it polymerizes in minutes.

    AI/ML Overview

    Here's a summary of the acceptance criteria and study findings for the SURGISEAL Stylus™ and Stylus Twist™ Topical Skin Adhesives, based on the provided text:

    Acceptance Criteria and Device Performance

    The submission discusses performance criteria generally, stating that the new applicator designs "demonstrated that the applicator design modification to the currently marketed product does not impact the performance specification criteria identified for the SURGISEAL product family." Specific numerical acceptance criteria are not provided in the excerpt.

    The general performance attributes tested and the qualitative results are:

    Acceptance Criteria CategorySpecific TestReported Device Performance
    BiocompatibilityCytotoxicity (ISO 10993-Part 5)No Cytotoxic Effect (PASS)
    ISO Intracutaneous Reactivity (ISO 10993-10)No Dermal Reactions (PASS)
    Primary Skin Irritation (ISO 10993-10)No Dermal Irritations (Pass)
    Device PerformanceFlexibilityDoes not impact performance specification criteria
    In-vitro wound closureDoes not impact performance specification criteria
    ViscosityDoes not impact performance specification criteria
    Set-timeDoes not impact performance specification criteria
    PurityDoes not impact performance specification criteria
    Surface CoverageDoes not impact performance specification criteria
    Linear CoverageDoes not impact performance specification criteria
    SterilizationSterilization by gamma irradiation (ISO 11137-2:2006)Achieves 10^-6^ SAL
    Sterilization by ethylene oxide (ISO 11135-1:2008 & 11135-2:2008)Achieves 10^-6^ SAL
    Shelf-LifeReal-time and accelerated aging studiesSame performance characteristics as predicate (2-year expiration)

    Study Details

    Here's the breakdown of the study details based on the provided text:

    1. Sample size used for the test set and the data provenance:

      • Test Set Sample Size: Not explicitly stated in terms of number of units or measurements for each performance test. The biocompatibility tests mention specific "Lots" (e.g., Lot James A, Lot x 5923, Lot 121512i), implying multiple samples were tested from these production batches.
      • Data Provenance: Not explicitly stated (e.g., country of origin). The studies appear to be bench testing ("In-vitro," "bench performance testing") and animal studies (implied by "Intracutaneous Reactivity," "Primary Skin Irritation"), rather than clinical studies on human subjects, based on the descriptive nature of the provided summary. All data appears to be retrospective as it compares to an already marketed device.
    2. Number of experts used to establish the ground truth for the test set and the qualifications of those experts: Not applicable. The ground truth for these performance and biocompatibility tests is based on objective, standardized test methods (e.g., ISO standards) and measurable outcomes, rather than expert interpretation of images or clinical cases.

    3. Adjudication method (e.g., 2+1, 3+1, none) for the test set: Not applicable. As the tests are objective and based on standardized protocols with pass/fail criteria or measurements, there's no mention of an adjudication process by human experts.

    4. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance: Not applicable. This device is a topical skin adhesive, not an AI-powered diagnostic or assistive tool for human readers.

    5. If a standalone (i.e., algorithm only without human-in-the-loop performance) was done: The device itself is a product for wound closure, not an algorithm. The performance tests are for the physical and biological characteristics of the adhesive and its applicator.

    6. The type of ground truth used (expert consensus, pathology, outcomes data, etc.): The ground truth for the biocompatibility tests is defined by the objective results of the ISO 10993 standards (e.g., absence of cytotoxic effect, dermal reactions, or irritations). For the performance tests, the ground truth is against pre-established "performance specification criteria identified for the SURGISEAL product family" (presumably internal quantitative targets for flexibility, viscosity, set-time, etc.).

    7. The sample size for the training set: Not applicable. This is not a machine learning or AI device that requires a training set.

    8. How the ground truth for the training set was established: Not applicable, as there is no training set for this type of device.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1